Stock Events

Stock Events

Nascent Biotech 

$0.000200
9
+$0.00+100%Tuesday 14:56

Statistics

Day High
0.0005
Day Low
0.0005
52W High
0.1345
52W Low
0.0001
Volume
15,000
Avg. Volume
22,233
Mkt Cap
34,443.4
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

Nov 10Expected
Q4 2020
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Q3 2022
-0.01
-0
0
0.01
Expected EPS
N/A
Actual EPS
-0.0012

Financials

-Profit Margin
Unprofitable
2018
2019
2020
2021
2022
2023
0Revenue
-2.09MNet Income

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Marker Therapeutics
MRKR
Mkt Cap16.34M
Marker Therapeutics, Inc. is a clinical-stage immuno-oncology company, working on novel therapies that could compete with Nascent's products.
PDS Biotechnology
PDSB
Mkt Cap104.36M
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company, developing a similar range of immunotherapies for cancer.
SELLAS Life Sciences Group
SLS
Mkt Cap1.95B
SELLAS Life Sciences Group, Inc. is involved in developing novel cancer immunotherapies, making it a competitor in the oncology space.

About

Nascent Biotech, Inc., a clinical-stage biopharmaceutical firm, is committed to creating monoclonal antibody-based treatments for various forms of cancer. A primary focus is Pritumumab, a therapeutic currently in development to address aggressive brain malignancies such as glioblastoma and malignant astrocytoma. This drug also targets numerous epithelial cancers, including those affecting the lung, breast, colon, brain, and pancreas. Additionally, the company is advancing MultiPharm, its proprietary technology platform, which holds promise for applications in cancer therapy, diabetes, autoimmune disorders, and transplantation. The company's headquarters are situated in Vero Beach, Florida.
Show More
CEO
Sean Carrick
Employees
2
Country
United States
ISIN
US63108Q1013

Listings

OTC Link
US
NBIO

0 Comments

Share your thoughts

FAQs

What is Nascent Biotech stock price today?▼
The current price of NBIO is $0.00 USD — it has increased by +100% in the past 24 hours. Watch Nascent Biotech stock price performance more closely on the chart.
What is Nascent Biotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Nascent Biotech stocks are traded under the ticker NBIO.
Is Nascent Biotech stock price growing?▼
NBIO stock has risen by +0% compared to the previous week, the month change is a +0% rise, over the last year Nascent Biotech has showed a -91.3% decrease.
What is Nascent Biotech market cap?▼
Today Nascent Biotech has the market capitalization of 34,443.4
What were Nascent Biotech earnings last quarter?▼
NBIO earnings for the last quarter are -0 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Nascent Biotech revenue for the last year?▼
Nascent Biotech revenue for the last year amounts to 0 USD.
What is Nascent Biotech net income for the last year?▼
NBIO net income for the last year is -2.09M USD.
How many employees does Nascent Biotech have?▼
As of November 3, 2026, the company has 2 employees.
In which sector is Nascent Biotech located?▼
Nascent Biotech operates in the Health & Wellness sector.
When did Nascent Biotech complete a stock split?▼
Nascent Biotech has not had any recent stock splits.
Where is Nascent Biotech headquartered?▼
Nascent Biotech is headquartered in North Palm Beach, United States.